Variant report
Variant | nsv581794 |
---|---|
Chromosome Location | chr2:49377390-49377986 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:49371083..49372770-chr2:49374962..49377778,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186792030 | chr2:49377428-49377429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542406268 | chr2:49377470-49377471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543413572 | chr2:49377479-49377480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs199566615 | chr2:49377480-49377481 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147460222 | chr2:49377487-49377488 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555337821 | chr2:49377489-49377490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139929238 | chr2:49377497-49377498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77182257 | chr2:49377499-49377500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs145499539 | chr2:49377533-49377534 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566360621 | chr2:49377543-49377544 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs557082933 | chr2:49377544-49377545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs4331540 | chr2:49377607-49377608 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs570163976 | chr2:49377628-49377629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76120380 | chr2:49377682-49377683 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192251099 | chr2:49377700-49377701 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs147296734 | chr2:49377703-49377704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148779737 | chr2:49377788-49377789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs142415641 | chr2:49377794-49377795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs151316996 | chr2:49377800-49377801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553824361 | chr2:49377817-49377818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182321627 | chr2:49377849-49377850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542416474 | chr2:49377877-49377878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs184990408 | chr2:49377886-49377887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573737128 | chr2:49377904-49377905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140609949 | chr2:49377947-49377948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564971011 | chr2:49377951-49377952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537912236 | chr2:49377970-49377971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49376400-49377400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr2:49376400-49377800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr2:49376600-49379800 | Weak transcription | HSMMtube | muscle |
4 | chr2:49377200-49379600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr2:49377400-49380400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr2:49377800-49379400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |